Clinical Immunology, Neuropharmacology and Drug Development

Immune drug therapy

Neuromuscular disorders embrace a wide-range of diseases poignant the peripheral system that consists of all the motor and sensory nerves that connect the brain and neuromuscular disorder to the remainder of the body. Progressive muscle weakness is that the predominant condition of those disorders.

We treat the complete scope of fasciculus disorders, including:

• 
  Diabetic pathology – nerve injury caused by polygenic disease
• 
  Amyotrophic lateral pathology (Lou Gehrig’s Disease) and different efferent neuron diseases – destroys cells that management striated muscle activity
• 
  Toxic pathology – pain and weakness caused by toxic substances
• 
  Small fiber pathology – affects the nerve endings of the skin
• 
  Autonomic neuropathies – injury to nerves that affects the centre, force per unit area, temperature, digestion and a lot of
• 
  Muscular disorders, hereditary:

• 
  Congenital myopathies – muscle weakness existing at birth


• 
  Muscular dystrophy – a gaggle of disorders involving muscle weakness


• 
  Metabolic myopathies – breakdown of muscles, cramping syndromes, exercise intolerance, as well as mitochondrial disorders


• 
  Muscular disorders, acquired:

• 
  Inclusion body inflammation – inflammatory muscle unwellness includes weakness and problem swallowing


• 
  Dermatomyositis – inflammatory muscle unwellness includes muscle weakness and eruption


• 
  Polymyositis – includes muscle weakness and inflammation


• 
  Necrotizing pathology – intensive muscle destruction

• 
  Neuromuscular junction disorders (dysfunction at location wherever nerves connect with muscles):

• 
  Myasthenia gravis – communication downside between nerves and muscles leads to muscle weakness and muscle fatigue
• 
  Lambert-Eaton Syndrome – usually coincides with cancer, inflicting muscle weakness